Controlling your
type 2 diabetes just
got easier with Revita®.

Revita is a new therapy that addresses a root cause of type 2 diabetes—in your gut.
This non-drug procedure is CE marked. Revita has been shown to reduce the need for insulin in people with T2D who were also prescribed Liraglutide.1 It is routinely performed in select hospitals in Germany, and is generally covered by public health insurance.*

1. van Baar et al. Gastrointest Endosc. 2021; 94:111-20
*Under the innovation-funding program (§ 137 h SGBV). Revita is clinically evaluated over a period of 5 years.